ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR FUCOSIDOSIS

被引:0
|
作者
VELLODI, A
CRAGG, H
WINCHESTER, B
YOUNG, E
YOUNG, J
DOWNIE, CJC
HOARE, RD
STOCKS, R
BANERJEE, GK
机构
[1] WESTMINSTER MED SCH & HOSP,BONE MARROW TRANSPLANT UNIT,LONDON,ENGLAND
[2] CHELSEA & WESTMINSTER HOSP,DEPT PSYCHOL,LONDON,ENGLAND
[3] CHURCHILL CLIN,MRI UNIT,LONDON,ENGLAND
[4] CHELSEA & WESTMINSTER HOSP,DEPT CHEM PATHOL,LONDON,ENGLAND
[5] JAMES PAGET HOSP,DEPT PAEDIAT,GREAT YARMOUTH,ENGLAND
关键词
FUCOSIDOSIS; ALLOGENEIC BONE MARROW; TRANSPLANT;
D O I
暂无
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
Bone marrow transplantation was performed on an 8-month-old boy who was diagnosed as having fucosidosis following the diagnosis of the disease in his older brother, Although he was asymptomatic and his development was normal, abnomalities were found on an MRI scan prior to transplant. In the absence of a suitable related donor, an unrelated volunteer donor was used, Conditioning for the transplant consisted of busulphan and cyclophosphamide. Graft-versus-host disease prophylaxis consisted of in vitro T cell-depletion of the bone marrow and in vivo administration of cyclosporin, The post-transplant period was complicated by moderately severe graft-versus-host disease, Engraftment was documented by the presence of donor levels of alpha-fucosidase, donor blood group and tissue type (difference in the Do antigen), and chromosomal polymorphism pattern of donor origin, Eighteen months after transplant, there is evidence of mild neurodevelopmental delay, By contrast, his elder sibling showed far greater developmental delay at the same age, The patient's MRI scan shows improvement, We believe this to be the first case of human fucosidosis treated by bone marrow transplantation.
引用
收藏
页码:153 / 158
页数:6
相关论文
共 50 条
  • [41] 50 years of allogeneic bone-marrow transplantation
    Powles, Ray
    LANCET ONCOLOGY, 2010, 11 (04): : 305 - 306
  • [42] ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR PRIMARY MYELOFIBROSIS
    IFRAH, N
    GARDEMBASPAIN, M
    HUNAULT, M
    SAINTANDRE, JP
    FOUSSARD, C
    BOASSON, M
    BRITISH JOURNAL OF HAEMATOLOGY, 1989, 73 (04) : 575 - 576
  • [43] PSORIASIS AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION
    GARDEMBASPAIN, M
    IFRAH, N
    FOUSSARD, C
    BOASSON, M
    SAINTANDRE, JP
    VERRET, JL
    ARCHIVES OF DERMATOLOGY, 1990, 126 (11) : 1523 - 1523
  • [44] HYPERAMMONEMIA FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION
    TSE, N
    CEDERBAUM, S
    GLASPY, JA
    AMERICAN JOURNAL OF HEMATOLOGY, 1991, 38 (02) : 140 - 141
  • [45] CURRENT STATUS OF ALLOGENEIC BONE-MARROW TRANSPLANTATION
    SOBOCINSKI, KA
    HOROWITZ, MM
    RIMM, AA
    BORTIN, MM
    BIOMEDICINE & PHARMACOTHERAPY, 1992, 46 (2-3) : 57 - 69
  • [46] ALLOGENEIC BONE-MARROW TRANSPLANTATION IN LEUKEMIA PATIENTS
    BORTIN, MM
    CURRENT PROBLEMS IN CANCER, 1986, 10 (01) : 1 - 52
  • [47] BONE-MARROW TRANSPLANTATION .1. ALLOGENEIC
    CHAO, NJ
    BLUME, KG
    WESTERN JOURNAL OF MEDICINE, 1989, 151 (06): : 638 - 643
  • [49] LATE COMPLICATIONS OF ALLOGENEIC BONE-MARROW TRANSPLANTATION
    BACIGALUPO, A
    VANLINT, MT
    FRASSONI, F
    OCCHINI, D
    GUALANDI, F
    LAMPARELLI, T
    MARMONT, AM
    MEDICAL ONCOLOGY AND TUMOR PHARMACOTHERAPY, 1991, 8 (04): : 261 - 263
  • [50] RECENT ADVANCES IN ALLOGENEIC BONE-MARROW TRANSPLANTATION
    GLUCKMAN, E
    SEMAINE DES HOPITAUX, 1980, 56 (41-4): : 1745 - 1747